about
Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.Microparticles and microscopic structures in three fractions of fresh cerebrospinal fluid in schizophrenia: case report of twins.The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteersHigh interleukin-6 and impulsivity: determining the role of endophenotypes in attempted suicide.Possible Biomarkers of Chronic Stress Induced Exhaustion - A Longitudinal StudyThe expression of HMGB1 on microparticles from Jurkat and HL-60 cells undergoing apoptosis in vitro.Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.A multicolor flow cytometric assay for measurement of platelet-derived microparticles.Comparison of venous and arterial blood sampling for the assessment of platelet aggregation with whole blood impedance aggregometry.CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L.Effect of lipopolysaccharide administration on the number, phenotype and content of nuclear molecules in blood microparticles of normal human subjects.Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?Formation of microparticles in the injured brain of patients with severe isolated traumatic brain injury.Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome.Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers.Microparticles reveal cell activation during IVF - a possible early marker of a prothrombotic state during the first trimester.Altered β2 -glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies.Reply to: "Endothelial progenitor cell release is usually considered a beneficial effect: Problems in interpreting the acute effects of e-cigarette use".Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.Platelet-derived microparticles during and after acute coronary syndrome.mPGES-1 deletion affects platelet functions in mice.Inflammation and thrombin generation cause increased thrombin activatable fibrinolysis inhibitor levels in experimental human endotoxemia.Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIsRelease of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled studyLow plasma vascular endothelial growth factor (VEGF) associated with completed suicideAtorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive diseaseMicroparticles as autoantigens in systemic lupus erythematosus
P50
Q30277266-101A23F7-98C8-45B3-9116-732F14F09F03Q34034540-B4022DDE-F434-4418-8823-B06BC3241B81Q35108949-6A4EF54D-BEFF-499F-A3AF-421D2AD4F9D7Q35150187-2C89F263-A445-4C90-BD84-B6E38B947CA1Q36008329-9F7B119B-D090-498A-A848-32DBC0044959Q38993235-A1422750-A80E-4294-86C8-E0C61B3ADFECQ39159683-BE156A2A-CE44-494D-97EB-86D7F07CA652Q42967820-EB0CDC23-49AC-45EB-BF5E-4F487FF79A83Q43235532-631DB19D-0EB2-4B92-BD91-A47675823473Q43515622-A6327008-3946-475C-BD2C-CE51AF03AED0Q43641406-9E8BAC48-0F55-47C1-97D0-E1997E3CE499Q44814556-CACC69DF-67A4-4B18-9639-16B37B8FD72FQ45807873-3996CC37-B873-4E9C-A532-38D7F75C48C1Q48701715-384567A4-E168-47D1-9F23-082C409207E9Q50802349-0EFD895B-6DE9-42B2-8BAA-8678E68A1988Q51447654-9B6DBA83-9FED-4EFD-A56C-43CDB3099E14Q51643385-E7059408-DAC3-478C-BADA-D59C79943ACFQ52589984-D1C35A18-BC08-40FD-80F2-3B9301EE0B5DQ52795499-489C4690-A02A-4A4E-A629-A4561D162061Q52915225-892BBD61-22FC-455E-B77E-365C560AF3B9Q52926108-7FCFE7D2-12EF-4360-AA2E-F0EACECC1625Q53058669-98F10FE7-D340-4454-8F61-164F7EA77342Q53182835-8AABF5F3-5E17-4311-BEF0-762E01B93831Q53563955-E9945EEE-9EA2-45A9-B46F-40239744F86AQ54384917-179C199B-C0A9-43B6-9A87-063EEFD44FFFQ60683342-C6C1256D-CA68-4893-8BF7-512ED195122EQ82248654-B89E343D-493B-46D3-AA01-C7B59F327455Q82582560-885E4F2A-BBBB-4E82-BF6F-30DB01C24461Q84198879-22A4DF0D-E608-49AF-B6F6-3CCBACB0D502Q90657176-54761DCB-401F-44EB-ADFA-8C1D9EA62CD9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fariborz Mobarrez
@ast
Fariborz Mobarrez
@en
Fariborz Mobarrez
@es
Fariborz Mobarrez
@nl
Fariborz Mobarrez
@sl
type
label
Fariborz Mobarrez
@ast
Fariborz Mobarrez
@en
Fariborz Mobarrez
@es
Fariborz Mobarrez
@nl
Fariborz Mobarrez
@sl
prefLabel
Fariborz Mobarrez
@ast
Fariborz Mobarrez
@en
Fariborz Mobarrez
@es
Fariborz Mobarrez
@nl
Fariborz Mobarrez
@sl
P106
P31
P496
0000-0002-7106-6248